Published in
Elsevier, Multiple Sclerosis and Related Disorders, (44), p. 102311, 2020
DOI: 10.1016/j.msard.2020.102311
Links
Tools
Prevention of rebound effect after natalizumab withdrawal in multiple sclerosis. Study of two high-dose methylprednisolone schedules
Journal article published in 2020 by
Luna Fuentes-Rumí 
,
Roćıo and Carreón-Guarnizo Ester Hernández-Clares ,
Ester Carreón-Guarnizo,
Gabriel and Iniesta-Martinez Francisca Valero-López,
Francisca Iniesta-Martinez ,
Jose Maria and León-Hernández Adelaida Cabrera-Maqueda,
Adelaida León-Hernández,
Joaqúın Zamarro-Parra ,
Ana Morales-Ortiz,
José E. Meca-Lallana
,
Roćıo and Carreón-Guarnizo Ester Hernández-Clares ,
Ester Carreón-Guarnizo,
Gabriel and Iniesta-Martinez Francisca Valero-López,
Francisca Iniesta-Martinez ,
Jose Maria and León-Hernández Adelaida Cabrera-Maqueda,
Adelaida León-Hernández,
Joaqúın Zamarro-Parra ,
Ana Morales-Ortiz,
José E. Meca-Lallana
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 